AB
Andrew Baum Citigroup Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$139B
| $24.49 | $26 |
6%
upside
| Neutral |
6 Aug ‘25
1 month ago |
|
2
Bristol-Myers Squibb
BMY
$94.7B
| $46.53 | $47 |
1%
upside
| Neutral |
1 Aug ‘25
1 month ago |
|
3
Merck
MRK
$210B
| $84 | $84 |
0%
upside
| Neutral |
14 May ‘25
3 months ago |
|
4
Royalty Pharma
RPRX
$15.5B
| $35.76 | $40 |
12%
upside
| Buy |
25 Oct ‘24
10 months ago |
|
5
AbbVie
ABBV
$369B
| $209.03 | $215 |
3%
upside
| Buy |
25 Oct ‘24
10 months ago |
|
6
Eli Lilly
LLY
$665B
| $741.96 | $895 |
21%
upside
| Buy |
2 Apr ‘24
1 year ago |
|
7
Alvotech
ALVO
$2.51B
| $8.06 | $10 |
24%
upside
| Neutral |
20 Oct ‘23
1 year ago |
|